🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉 🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉
AstraZeneca purchases Amgen's biologic site

Singapore: AstraZeneca has bought bulk biologics manufacturing capacity from Amgen in US to expand its biologics manufac...

September 14, 2015 | Monday | News
Patrys gets US patent for antibody PAT-LM1

Singapore: United States Patent Office has issued official "Letters Patent" on a key patent in the PAT-LM1 family; US pa...

November 8, 2013 | Friday | News
AstraZeneca, Orexo to do respiratory drug trials

Singapore: Orexo entered into an agreement with AstraZeneca regarding preclinical program OX-CLI for a potential novel t...

January 25, 2013 | Friday | News
Progenics initiates Fuji's Phase 2 Trial for prostate cancer drug in Japan

New York-based Progenics Pharmaceuticals' partner Fujifilm RI Pharma Co. Ltd. (Fuji) has dosed the first patient in its ...

April 8, 2015 | Wednesday | News
BI, Crystal to co-develop therapeutic antibodies

Singapore: European firms, Crystal Bioscience and Boehringer Ingelheim, have entered into an agreement to collaborate on...

January 10, 2014 | Friday | News
Daiichi Sankyo Espha's TB drugs approved in Japan

Japan' Daiichi Sankyo's domestic subsidiary, Daiichi Sankyo Espha Co Ltd. has obtained approval for partial changes conc...

August 25, 2015 | Tuesday | News
ASLAN receives orphan drug designation for cancer drug

Singapore: ASLAN Pharmaceuticals, Singapore based biotech company focused on the development of immunotherapies and targ...

August 13, 2015 | Thursday | News
GVK Bio establishes largest isotope labeling factory in India

Hyderabad: GVK Biosciences, Asia's leading drug discovery R&D organization, has received approvals from the Atomic ...

November 20, 2012 | Tuesday | News
BMS, Japan firm collaborate to develop new immunotherapies

Singapore: Japan's Kyowa Hakko Kirin and Bristol-Myers Squibb have entered into a clinical trial collaboration agreement...

July 30, 2015 | Thursday | News
Takeda, Immunogen in a cancer drug deal

Singapore: Immunogen has inked a pact with Japanese drugmaker Takeda pharmaceuticals that gives Takeda exclusive rights ...

March 25, 2015 | Wednesday | News
Suven secures patents in four countries

Singapore: The granted claims of the patent include the class of selective H3 ligands discovered by Suven and are being...

February 21, 2015 | Saturday | News
WHO launches emergency response to drug resistance

Singapore: On World Malaria Day, April 25, the WHO recognized significant accomplishments made in preventing and control...

April 25, 2013 | Thursday | News
Roche study: Obinutuzumab better than Rituxan

Singapore: Roche reported that an independent data monitoring committee has obtained positive results from the phase III...

July 25, 2013 | Thursday | News
Astellas, KEK sign deal for neglected diseases research

Singapore: The High Energy Accelerator Research Organization (KEK) and Japan-based Astellas Pharma have concluded an agr...

September 26, 2012 | Wednesday | News
Alzheimer's research gets a push from Servier

Singapore: Research on treatment of Alzheimer's disease received a fillip with Australian scientists working on it recei...

October 2, 2012 | Tuesday | News
Brisbane biotech secures $14 mn for drug discovery

Singapore: The University of Queensland-based biotechnology company Protagonist Therapeutics has secured $14 million in ...

July 10, 2013 | Wednesday | News
NZ firm migrates to Aus to capitalize on MS drug

Singapore: New Zealand-based biopharmaceutical company Innate Immunotherapeutics is migrating to Australia in a move to ...

September 11, 2013 | Wednesday | News
Dengue incurs annual cost of $950 mn to SE Asia

Philippines: The economic burden churned by mosquito borne disease, dengue, is costing upto $950 million to south east A...

June 20, 2014 | Friday | Analysis